First Trust NYSE Arca Biotechnology Index Fund (FBT)

Delayed Data
As of Mar 20
 -0.30 / -0.22%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology IndexSM. The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. It is non-diversified.

4 Sector ETFs That Crushed S&P 500 in 9-Year Bull Run
Mar 09 / - Paid Partner Content
9 ETFs Winners From 9-Year Bull Run
Mar 09 / - Paid Partner Content
9 ETFs That Emerged Bulls From the Bottom of Bear Market
Mar 09 / - Paid Partner Content
4 Hot Sector ETFs Springing Up to Rank #1
Mar 07 / - Paid Partner Content


1 month+0.47% 3 years+3.38%
3 months+13.52% 5 years+21.38%
1 year+31.68% Since inception+18.07%
Data through 03/20/2018

Quote Details

Previous close$138.94
Open day’s range137.81 – 139.43
Net asset value (NAV)138.92 (03/19/2018)
Daily volume48,388
Average volume (3 months)63,395
Data as of 8:00pm ET, 03/20/2018

Peer Comparisonvs. Health ETFs

Performance 5-yr return+21.38%+17.28%
Expense Gross exp ratio0.56%1.30%
Risk 5 year sharpe ratio0.941.02
Net assets$1.4B$3.1B
Average market cap$11.5B$10.4B
Average P/E31.222.9
Dividend / Share--0.34%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
-- 5.38%
-- 4.20%
NKTR Nektar Therapeutics3.97%
FGEN FibroGen Inc3.78%
AGIO Agios Pharmaceuticals Inc3.78%
IONS Ionis Pharmaceuticals Inc3.48%
VRTX Vertex Pharmaceuticals Inc3.46%
NBIX Neurocrine Biosciences Inc3.44%
ICPT Intercept Pharmaceuticals Inc3.40%
QGEN Qiagen NV3.38%